Print Published 28th Sep 2018, 14:20

Huntsworth paying premium price for Navience?

Huntsworth’s proposed acquisition of the US payer and marketing consultancy Navience Healthcare Solutions seems to have been finalised on rather generous terms although the company told Marketing Services Financial Intelligence that it is very happy with the terms.

Initially Huntsworth will buy 80% of Navience for $24 million (£18.3 million) subject to any working capital adjustment arising at completion.  A further earnout payment will become due for the two years ending 31 December 2019, subject to an overall cap of $40 million for the 80% tranche.

The seller John Shamsey is the founder and sole shareholder in Navience.